As a College of American Pathologists (CAP) accredited biorepository, the UC Davis Comprehensive Cancer Center Biorepository Shared Resource (CCB) provides quality cancer and non-cancer related human biospecimens that are procured, stored and annotated using international standards of best practices and protocols that are Office for Human Research Protection (OHRP) compliant. The biorepository functions as a centralized tissue bank that provides all Cancer Center members and their research collaborators with access to high-quality cancer and non-cancer related specimens and histology services. Tissue samples are a valuable, but finite, resource; thus much effort is put forth to ensure standardized specimen collection, processing and storage procedures. The goal of the CCB is to maximize use of specimens in a cost- and labor- effective, ethical, state of the art manner. Three IRB approved protocols allow for fresh/frozen remainder tissue collected from surgical procedures via (1) pre-op and (2) post-op consent as well as (3) access to all paraffin blocks at the Pathology Department. In addition, the CCB provides collection and storage for specimens collected for various other Cancer Center programs such as the lung cancer, breast cancer, and the genitourinary (GU) program. The primary objectives of the CCB shared resource are to facilitate cancer related research at UC Davis by: 1) Procuring, preparing, storing and dispersing malignant, benign and normal human biospecimens from a centralized biorepository that were collected using standardized procedures and continuously audited quality management programs. 2) Providing high quality pathological and clinical annotated data using a secure and interactive on-line database system (caTissue). 3) Ensuring compliance with all mandated regulatory processes (HHS, IRB, HIPAA, SRC) thereby promoting ethical research by UC Davis researchers. 4) Providing experienced pathologic consultation to investigators using human specimens for scientific correlation. 5) Efficiently prioritizing, tracking and dispersing biospecimen requests via a rapid and standardized, web- based approval and monitoring process. 6) Providing Tissue Microarray (TMA) construction and histology services for cancer center investigators and their collaborators. The objectives and goals of the CCB are to facilitate scientific interactions and enhance scientific productivity by providing well-characterized, high-quality specimens with annotated data for clinical and basic science research purposes while protecting patient confidentiality.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA093373-18
Application #
9993291
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
18
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Riess, Jonathan W; Gandara, David R; Frampton, Garrett M et al. (2018) Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC. J Thorac Oncol 13:1560-1568
Withers, Sita S; Moore, Peter F; Chang, Hong et al. (2018) Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs. Dev Comp Immunol 87:64-74
Zhang, Jin; Xu, Enshun; Ren, Cong et al. (2018) Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN. Cancer Res 78:1511-1521
Rowson-Hodel, A R; Wald, J H; Hatakeyama, J et al. (2018) Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. Oncogene 37:197-207
Wang, Minan; Yao, Li-Chin; Cheng, Mingshan et al. (2018) Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J 32:1537-1549
York, D; Sproul, C D; Chikere, N et al. (2018) Expression and targeting of transcription factor ATF5 in dog gliomas. Vet Comp Oncol 16:102-107
Fletcher, Kyle; Klosterman, Steven J; Derevnina, Lida et al. (2018) Comparative genomics of downy mildews reveals potential adaptations to biotrophy. BMC Genomics 19:851
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Yuan, Ye; He, Yixuan; Bo, Ruonan et al. (2018) A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging. Nanoscale 10:21634-21639
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987

Showing the most recent 10 out of 836 publications